Literature DB >> 15370286

A novel electrophoretic technique designed to modify the ratio of magnesium isotopes inside the creatine kinase active sites. A preliminary report.

Dmitri A Kouznetsov1, Stanislav E Arkhangelsky, Alana G Berdieva, Peter Z Khasigov, Marina A Orlova.   

Abstract

A simple and efficient preparative electrophoretic technique has been proposed to obtain a modified creatine kinase (CK, E.C.2.7.3.2) molecule with an increased content of 25Mg in the active site. A key point of the method is the special design of a 0.9 x 12.0 cm column for ascendent electrophoresis, packed consecutively, from the bottom to the top, with layers of 30 % PAAG (polyacrylamide grade), 25Mg2+ -containing 7.5 % PAAG, enzyme-binding ADP Sepharose and 2.2 % agarose gels, based on different tris-glycine and tris-HCl separation buffer systems. The isotope substitution process was a result of simultaneous desorption of enzyme from ADP Sepharose and electrically directed extensive flow of 25Mg2+ cations through the porous gel matrix. Greater than 8-fold 25Mg enrichment, i.e. a 10.2-86.3 % increase of 25Mg contribution to total enzyme magnesium, has been reached. The modified 25Mg-rich CK samples manifest higher (2.4-fold increase) values of specific catalytic activity when compared with intact (control) ones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370286     DOI: 10.1080/10256010410001689916

Source DB:  PubMed          Journal:  Isotopes Environ Health Stud        ISSN: 1025-6016            Impact factor:   1.675


  2 in total

1.  Reexamination of magnetic isotope and field effects on adenosine triphosphate production by creatine kinase.

Authors:  Darragh Crotty; Gary Silkstone; Soumya Poddar; Richard Ranson; Adriele Prina-Mello; Michael T Wilson; J M D Coey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-23       Impact factor: 11.205

2.  Oligomerization of β-Like DNA Polymerases in the Presence of Fe2+ Ions.

Authors:  S V Stovbun; A S Vedenkin; D V Zlenko; A A Bukhvostov; D A Kuznetsov
Journal:  Bull Exp Biol Med       Date:  2022-10-10       Impact factor: 0.737

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.